Skip to content
healthcare.dev

Triamterene and Hydrochlorothiazide

NDC 70518-1662, Triamterene and Hydrochlorothiazide, tablet, from REMEDYREPACK INC..

Product NDC
70518-1662
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA073449
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-1662 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRIAMTERENE37.5 mg/1
  • HYDROCHLOROTHIAZIDE25 mg/1

Pharmacologic classes

Decreased Renal K+ Excretion [PE]; Increased Diuresis [PE]; Increased Diuresis [PE]; Potassium-sparing Diuretic [EPC]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
70518-1662-07051816620030 TABLET in 1 BLISTER PACK (70518-1662-0)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/43425ec7-a2c0-41d8-b759-b7b5918949ce

Use it

Look up 70518-1662 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-1662 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-1662. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.